Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04777539
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-19
First Post:
2021-02-23
Brief Title:
Comparing the Safety and Benefit of Natalizumab Tysabri At-home Infusion vs At-hospital Infusion in Multiple Sclerosis
Sponsor:
Nantes University Hospital
Organization:
Nantes University Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-14
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-05-15
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-23
First Submit QC Date:
March 1 2021
Study First Post Date:
2021-03-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-18
Last Update Post Date:
2024-03-19
Last Update Post Date Type:
ACTUAL